4//SEC Filing
Chivukula Pad 4
Accession 0001193805-23-000516
CIK 0001768224other
Filed
Apr 4, 8:00 PM ET
Accepted
Apr 5, 8:47 PM ET
Size
5.3 KB
Accession
0001193805-23-000516
Insider Transaction Report
Form 4
Chivukula Pad
Chief Scientific Officer & COO
Transactions
- Sale
Common Stock
2023-04-03$25.38/sh−5,000$126,900→ 584,448 total
Footnotes (2)
- [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- [F2]Reflects the weighted average price of 5,000 shares of common stock of Arcturus Therapeutics Holdings Inc. sold by the Reporting Person in multiple transactions April 3, 2023 with sale prices ranging from $23.56 to $26.12 per share. The Reporting Person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
Documents
Issuer
Arcturus Therapeutics Holdings Inc.
CIK 0001768224
Entity typeother
Related Parties
1- filerCIK 0001727317
Filing Metadata
- Form type
- 4
- Filed
- Apr 4, 8:00 PM ET
- Accepted
- Apr 5, 8:47 PM ET
- Size
- 5.3 KB